Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease
- PMID: 7619020
- DOI: 10.1001/archneur.1995.00540310029012
Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease
Abstract
Objective: To examine the clinical consequences of periventricular white-matter lesions on computed tomography (CT) and magnetic resonance imaging (MRI) scans in probable Alzheimer's disease.
Design: Case series, 12-month follow-up.
Setting: Multidisciplinary behavioral neurology research clinic.
Patients: We longitudinally evaluated the clinical characteristics of 27 patients with probable AD for whom both CT and MRI scans had been performed at baseline.
Interventions: None.
Main outcome measure: The presence of abnormal neurological signs was examined at baseline and at a 12-month examination.
Results: Periventricular white-matter lesions were observed with CT in 12 patients (44%) and with MRI in 21 patients (78%). Computed tomography did not detect lesions of 1 to 3 mm, as were seen on MRI scans, and CT also did not detect lesions of 4 to 10 mm when they occurred in the deep subcortical white matter and were not part of a greater confluent lesion. There was no relationship between the severity of periventricular white-matter lesions with either neuroimaging method and the presence of abnormal neurological signs. However, there was a greater frequency of periventricular white-matter lesions shown on CT scans than on MRI scans at baseline in patients in whom abnormal neurological signs (eg, abnormal gait, asymmetric deep tendon reflexes, focal motor deficits, abnormal plantar response) developed at 12-month follow-up.
Conclusion: Although MRI may be more sensitive in detecting periventricular white-matter lesions, CT is more specific in predicting subsequent symptomatic cerebrovascular disease.
Similar articles
-
Electroencephalographic correlates of periventricular white matter lesions in probable Alzheimer's disease.Dementia. 1995 Nov-Dec;6(6):343-7. doi: 10.1159/000106968. Dementia. 1995. PMID: 8563788 Clinical Trial.
-
White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders.Int J Geriatr Psychiatry. 2005 Mar;20(3):274-9. doi: 10.1002/gps.1283. Int J Geriatr Psychiatry. 2005. PMID: 15717341
-
White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1458-65. doi: 10.1136/jnnp.57.12.1458. J Neurol Neurosurg Psychiatry. 1994. PMID: 7798973 Free PMC article. Clinical Trial.
-
The basal ganglia and apraxia.Brain. 1996 Feb;119 ( Pt 1):319-40. doi: 10.1093/brain/119.1.319. Brain. 1996. PMID: 8624692 Review.
-
Imaging of white matter lesions.Cerebrovasc Dis. 2002;13 Suppl 2:21-30. doi: 10.1159/000049146. Cerebrovasc Dis. 2002. PMID: 11901239 Review.
Cited by
-
Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation.Chin J Integr Med. 2010 Jun;16(3):276-82. doi: 10.1007/s11655-010-0276-8. Epub 2010 Aug 8. Chin J Integr Med. 2010. PMID: 20694785 Review.
-
An ensemble-of-classifiers based approach for early diagnosis of Alzheimer's disease: classification using structural features of brain images.Comput Math Methods Med. 2014;2014:862307. doi: 10.1155/2014/862307. Epub 2014 Sep 9. Comput Math Methods Med. 2014. PMID: 25276224 Free PMC article.
-
Temporal lobe atrophy and white matter lesions are related to major depression over 5 years in the elderly.Neuropsychopharmacology. 2010 Dec;35(13):2638-45. doi: 10.1038/npp.2010.176. Epub 2010 Sep 29. Neuropsychopharmacology. 2010. PMID: 20881949 Free PMC article.
-
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.Neurology. 2004 Jul 27;63(2):220-7. doi: 10.1212/01.wnl.0000130531.90205.ef. Neurology. 2004. PMID: 15277612 Free PMC article.
-
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment.Alzheimers Dement (N Y). 2020 Nov 11;6(1):e12056. doi: 10.1002/trc2.12056. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33209971 Free PMC article.